Eyebiotech

New York, United States

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

$65.0M raised

Nov 2023

Series A

Top Investors

Jeito CapitalSV Health InvestorsSamsara BioCapitalVertex Ventures HCOmega Funds

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eyebiotech raised?

Eyebiotech has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are Eyebiotech's investors?

Eyebiotech's investors include Jeito Capital, SV Health Investors, Samsara BioCapital, Vertex Ventures HC, Omega Funds.

Where is Eyebiotech headquartered?

Eyebiotech is headquartered in New York, United States.

What does Eyebiotech do?

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

What stage is Eyebiotech at?

Eyebiotech is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 14, 2023.

MLA

"Eyebiotech — Funding & Investors." VCBacked, November 14, 2023, https://www.vcbacked.co/company/eyebiotech. Accessed June 4, 2026.

APA

VCBacked. (2023). Eyebiotech — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/eyebiotech

Wikipedia (cite web)

{{cite web |title=Eyebiotech — Funding & Investors |url=https://www.vcbacked.co/company/eyebiotech |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 14, 2023.